small molecule

RIDAURA

AURANOFIN

Loss of exclusivityloss of exclusivity
CompanyLEGACY PHARMA INC

Drug detail

Brand nameRIDAURA
Active ingredientAURANOFIN
Strength3MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMay 1985
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

RIDAURA patent cliff — loss of exclusivity — | CliffBio